{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:14:15Z","timestamp":1788311655144,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for health and Care Research","doi-asserted-by":"publisher","award":["NIHR303584"],"award-info":[{"award-number":["NIHR303584"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To achieve expert consensus on structured prostate MRI criteria for gadolinium-based contrast agent (GBCA) administration and whole-body MRI (WB-MRI) escalation in the diagnostic evaluation and staging of prostate cancer (PCa).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A three-round modified online Delphi survey was conducted among UK specialist prostate radiologists. Participants rated predefined clinical and MRI criteria using structured Likert agreement scales and provided free-text comments to refine decision-making. Quantitative responses were summarised descriptively. Qualitative thematic analysis informed subsequent rounds. Consensus for each decision criterion was predefined as \u2265 70% agreement. The study was conducted in accordance with CREDES (Conducting and Reporting of Delphi Studies) guidance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The number of radiologists who completed Rounds 1, 2, and 3 was 21, 14, and 11, respectively. Two principal outputs were defined: (1) consensus criteria for GBCA administration; (2) consensus criteria for WB-MRI escalation. For GBCA administration, consensus supported its use for Prostate Imaging-Reporting and Data System (PI-RADS) 3 lesions (86%) and low prostate imaging quality (PI-QUAL\u2009\u2264\u20093; 91%), and avoidance in high-quality (PI-QUAL 4\u20135) images (73%). Fixed prostate-specific antigen (PSA) or PSA density thresholds did not reach consensus when considered in isolation. For WB-MRI, consensus supported escalation for T3a\/T3b disease (93%), combined clinical and radiological suspicion of metastasis (91%), and high-risk profiles (PSA\u2009\u2265\u200920\u2009ng\/mL, Gleason \u2265 8 or \u2265 T3; 86%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This Delphi study established expert consensus on structured MRI criteria to guide selective GBCA administration and WB\u2011MRI escalation, with the potential to reduce unnecessary GBCA administration, improve consistency and optimise prostate MRI workflow.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Question<\/jats:bold>\n                            What consensus-based criteria can guide on-table gadolinium-based contrast agent administration and whole-body MRI escalation during prostate MRI to reduce variability and unnecessary imaging?\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Findings<\/jats:bold>\n                            Delphi consensus established imaging-based criteria integrating lesion suspicion, image quality and high-risk features to guide selective gadolinium-based contrast agent administration and whole-body MRI escalation.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:bold>Critical relevance statement<\/jats:bold>\n                            This article critically evaluates gadolinium-based contrast agent administration in prostate MRI and defines consensus-based standardised decision-making criteria. These criteria aim to reduce unnecessary gadolinium-based contrast agent administration and improve efficiency and consistency in staging pathways.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02388-0","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:35:34Z","timestamp":1788309334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Delphi consensus of specialist radiologists on imaging criteria for gadolinium contrast use and whole-body MRI in prostate cancer"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-4474","authenticated-orcid":false,"given":"Eric Nduka","family":"Onwuharine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander James","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dimmock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"2388_CR1","unstructured":"National Institute for Health and Care Excellence (NICE) (2021) Prostate cancer: diagnosis and management. NICE guideline [NG131]. Available via https:\/\/www.nice.org.uk\/guidance\/ng131 Accessed 19 Nov 2025"},{"key":"2388_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrclinonc.2014.73","volume":"11","author":"L Klotz","year":"2014","unstructured":"Klotz L, Emberton M (2014) Management of low risk prostate cancer: active surveillance and focal therapy. Nat Rev Clin Oncol 11:324\u2013334","journal-title":"Nat Rev Clin Oncol"},{"key":"2388_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/1756287221997186","volume":"13","author":"A Saltman","year":"2021","unstructured":"Saltman A, Zegar J, Haj-Hamed M, Verma S, Sidana A (2021) Prostate cancer biomarkers and multiparametric MRI: Is there a role for both in prostate cancer management? Ther Adv Urol 13:1756287221997186","journal-title":"Ther Adv Urol"},{"key":"2388_CR4","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/jcm13082193","volume":"13","author":"F Iacobellis","year":"2024","unstructured":"Iacobellis F, Di Serafino M, Russo C et al (2024) Safe and informed use of gadolinium-based contrast agent in body magnetic resonance imaging: where we were and where we are. J Clin Med 13:2193","journal-title":"J Clin Med"},{"key":"2388_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/jmri.25625","volume":"46","author":"TJ Fraum","year":"2017","unstructured":"Fraum TJ, Ludwig DR, Bashir MR, Fowler KJ (2017) Gadolinium-based contrast agents: a comprehensive risk assessment. J Magn Reson Imaging 46:338\u2013353","journal-title":"J Magn Reson Imaging"},{"key":"2388_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1148\/radiol.2019182834","volume":"292","author":"JS McDonald","year":"2019","unstructured":"McDonald JS, Hunt CH, Kolbe AB et al (2019) Acute adverse events following gadolinium-based contrast agent administration: a single-center retrospective study of 281 945 injections. Radiology 292:620\u2013627","journal-title":"Radiology"},{"key":"2388_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/j.ackd.2017.03.004","volume":"24","author":"M Ramalho","year":"2017","unstructured":"Ramalho M, Ramalho J, Burke LM, Semelka RC (2017) Gadolinium retention and toxicity: an update. Adv Chronic Kidney Dis 24:138\u2013146","journal-title":"Adv Chronic Kidney Dis"},{"key":"2388_CR8","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.3390\/ijerph18147214","volume":"18","author":"MA Khairinisa","year":"2021","unstructured":"Khairinisa MA, Ariyani W, Tsushima Y, Koibuchi N (2021) Effects of gadolinium deposits in the cerebellum: reviewing the literature from in vitro laboratory studies to in vivo human investigations. Int J Environ Res Public Health 18:7214","journal-title":"Int J Environ Res Public Health"},{"key":"2388_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1590\/s1677-5538.ibju.2018.0102","volume":"44","author":"TC Mussi","year":"2018","unstructured":"Mussi TC, Martins T, Dantas GC et al (2018) Comparison between multiparametric MRI with and without post-contrast sequences for clinically significant prostate cancer detection. Int Braz J Urol 44:1129\u20131138","journal-title":"Int Braz J Urol"},{"key":"2388_CR10","doi-asserted-by":"publisher","first-page":"W226","DOI":"10.2214\/AJR.18.19880","volume":"211","author":"S Woo","year":"2018","unstructured":"Woo S, Suh CH, Kim SY, Cho JY, Kim SH, Moon MH (2018) Head-to-head comparison between biparametric and multiparametric MRI for the diagnosis of prostate cancer: a systematic review and meta-analysis. AJR Am J Roentgenol 211:W226\u2013W241","journal-title":"AJR Am J Roentgenol"},{"key":"2388_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00345-018-2428-y","volume":"37","author":"D Junker","year":"2019","unstructured":"Junker D, Steinkohl F, Fritz V et al (2019) Comparison of multiparametric and biparametric MRI of the prostate: Are gadolinium-based contrast agents needed for routine examinations? World J Urol 37:691\u2013699","journal-title":"World J Urol"},{"key":"2388_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 76:340\u2013351","journal-title":"Eur Urol"},{"key":"2388_CR13","doi-asserted-by":"crossref","unstructured":"Kalidindi S, Gandhi S (2023) Workforce crisis in radiology in the UK and the strategies to deal with it: Is artificial intelligence the saviour? Cureus 15:e43866","DOI":"10.7759\/cureus.43866"},{"key":"2388_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3348\/kjr.2023.0831","volume":"24","author":"S Jeganathan","year":"2023","unstructured":"Jeganathan S (2023) The growing problem of radiologist shortages: Australia and New Zealand\u2019s perspective. Korean J Radiol 24:1043\u20131045","journal-title":"Korean J Radiol"},{"key":"2388_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2214\/AJR.20.24268","volume":"216","author":"IG Schoots","year":"2021","unstructured":"Schoots IG, Barentsz JO, Bittencourt LK et al (2021) PI-RADS Committee position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review. AJR Am J Roentgenol 216:3\u201319","journal-title":"AJR Am J Roentgenol"},{"key":"2388_CR16","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","volume":"32","author":"F Hasson","year":"2000","unstructured":"Hasson F, Keeney S, McKenna H (2000) Research guidelines for the Delphi survey technique. J Adv Nurs 32:1008\u20131015","journal-title":"J Adv Nurs"},{"key":"2388_CR17","doi-asserted-by":"publisher","first-page":"e20476","DOI":"10.1371\/journal.pone.0020476","volume":"6","author":"R Boulkedid","year":"2011","unstructured":"Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C (2011) Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One 6:e20476","journal-title":"PLoS One"},{"key":"2388_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/0269216317690685","volume":"31","author":"S J\u00fcnger","year":"2017","unstructured":"J\u00fcnger S, Payne SA, Brine J, Radbruch L, Brearley SG (2017) Guidance on conducting and reporting Delphi studies (CREDES) in palliative care: recommendations based on a methodological systematic review. Palliat Med 31:684\u2013706","journal-title":"Palliat Med"},{"key":"2388_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.radi.2025.103214","volume":"32","author":"EN Onwuharine","year":"2025","unstructured":"Onwuharine EN, Clark AJ, McIntyre A, Hill J, Dimmock M (2025) Clinical and MRI variables in decision support systems for prostate MRI: a systematic review of decision support tools, nomograms, and risk models. Radiography 32:103214","journal-title":"Radiography"},{"key":"2388_CR20","doi-asserted-by":"crossref","unstructured":"Keeney S, McKenna HP, Hasson F (2011) The Delphi technique in nursing and health research. Wiley-Blackwell, Oxford","DOI":"10.1002\/9781444392029"},{"key":"2388_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.im.2003.11.002","volume":"42","author":"C Okoli","year":"2004","unstructured":"Okoli C, Pawlowski SD (2004) The Delphi method as a research tool: an example, design considerations and applications. Inf Manag 42:15\u201329","journal-title":"Inf Manag"},{"key":"2388_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/psych4020013","volume":"4","author":"DB Allsop","year":"2022","unstructured":"Allsop DB, Chelladurai JM, Kimball ER, Marks LD, Hendricks JJ (2022) Qualitative methods with NVivo software: a practical guide for analyzing qualitative data. Psych 4:142\u2013159","journal-title":"Psych"},{"key":"2388_CR23","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1007\/s00330-020-06929-z","volume":"30","author":"M de Rooij","year":"2020","unstructured":"de Rooij M, Isra\u00ebl B, Tummers M et al (2020) ESUR\/ESUI consensus statements on multiparametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists\u2019 training. Eur Radiol 30:5404\u20135416","journal-title":"Eur Radiol"},{"key":"2388_CR24","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2020209031","volume":"2","author":"SJ Withey","year":"2020","unstructured":"Withey SJ, Amlani A (2020) The added value of dynamic contrast-enhanced sequences in prostate MRI. Radiol Imaging Cancer 2:e209031","journal-title":"Radiol Imaging Cancer"},{"key":"2388_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.620628","volume":"11","author":"J Zeng","year":"2021","unstructured":"Zeng J, Cheng Q, Zhang D, Fan M, Shi C, Luo L (2021) Diagnostic ability of dynamic contrast-enhanced magnetic resonance imaging for prostate cancer and clinically significant prostate cancer in equivocal lesions: a systematic review and meta-analysis. Front Oncol 11:620628","journal-title":"Front Oncol"},{"key":"2388_CR26","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211372","volume":"95","author":"E Karanasios","year":"2022","unstructured":"Karanasios E, Caglic I, Zawaideh JP, Barrett T (2022) Prostate MRI quality: clinical impact of the PI-QUAL score in prostate cancer diagnostic work-up. Br J Radiol 95:20211372","journal-title":"Br J Radiol"},{"key":"2388_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.110930","volume":"165","author":"JJ F\u00fctterer","year":"2023","unstructured":"F\u00fctterer JJ, Tempany C (2023) Prostate MRI and image quality: the radiologist\u2019s perspective. Eur J Radiol 165:110930","journal-title":"Eur J Radiol"},{"key":"2388_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2024.100588","volume":"13","author":"N Nishioka","year":"2024","unstructured":"Nishioka N, Fujima N, Tsuneta S et al (2024) Enhancing the image quality of prostate diffusion-weighted imaging in patients with prostate cancer through model-based deep learning reconstruction. Eur J Radiol Open 13:100588","journal-title":"Eur J Radiol Open"},{"key":"2388_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-02973-1","volume":"15","author":"M Orman","year":"2025","unstructured":"Orman M, \u015eirolu S, Seker ME et al (2025) Multicenter analysis for inter-reader agreement of PI-QUAL score v2 for basic readers in prostate MRI. Sci Rep 15:22865","journal-title":"Sci Rep"},{"key":"2388_CR30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","volume":"3","author":"F Giganti","year":"2020","unstructured":"Giganti F, Allen C, Emberton M et al (2020) Prostate Imaging Quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial. Eur Urol Oncol 3:615\u2013619","journal-title":"Eur Urol Oncol"},{"key":"2388_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41391-017-0024-7","volume":"21","author":"T Nordstr\u00f6m","year":"2018","unstructured":"Nordstr\u00f6m T, Akre O, Aly M, Gr\u00f6nberg H, Eklund M (2018) Prostate-specific antigen density in the diagnostic algorithm of prostate cancer. Prostate Cancer Prostatic Dis 21:57\u201363","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2388_CR32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41391-024-00893-1","volume":"28","author":"AM Fang","year":"2025","unstructured":"Fang AM, Chapin BF, Shi CW et al (2025) Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer. Prostate Cancer Prostatic Dis 28:761\u2013766","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2388_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20132024 update. Part I: Screening, diagnosis, and local treatment with curative intent. Eur Urol 86:148\u2013163","journal-title":"Eur Urol"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02388-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02388-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02388-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:35:35Z","timestamp":1788309335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02388-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2388"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02388-0","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Keele University Review Board, REC Project Reference 0971. Electronic informed consent was obtained from all participants (radiologists).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest relevant to this study.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"216"}}